Parents File Case Against Serum Institute Over Daughter’s Alleged Death Due To Covishield
Parents File Case Against Serum Institute Over Daughter’s Alleged Death Due To Covishield
Covishield is an Indian variant of AstraZeneca’s Covid-19 vaccine, produced by Serum Institute of India. AstraZeneca has admitted in the trial that their vaccine could cause low platelet counts and formation of blood clots in rare cases.
May 3, 2024
By Sukhmani Kooner
AstraZeneca, a pharmaceutical giant, is undergoing a lawsuit in the United Kingdom over its vaccine’s link to Thrombosis with Thrombocytopenia Syndrome. It has admitted in the trial that its AZD1222 vaccine, which was produced in India by the Serum Institute of India (SII), Pune as Covishield, could cause low platelet counts and form blood clots in very rare cases. Around 175 crore Covishield doses have been administered all over India.
The parents of a lady, Karunya, who received Covishield, have filed a lawsuit against Serum Institute. Following the vaccine dose, Karunya passed away in July 2021. However, the national commission established by the Union Government found “insufficient” evidence to connect her death to the vaccine.
After the revelations made by AstraZeneca, the victim’s father, Venugopalan Govindan, will now file a writ suit asking for damages and the formation of an independent medical board to look into the cause of his daughter’s death.
The aggrieved father told a newspaper, “Both AstraZeneca and Serum Institute should have stopped the vaccine’s manufacture and supply when 15 European countries either suspended or age-limited these due to deaths from blood clots that happened in March 2021, within a couple of months of the rollout of the vaccine itself.”
The UK litigation AstraZeneca is facing prompted the corporation to disclose this side effect. Jamie Scott filed the claim because he got the AstraZeneca vaccine in April 2021 and experienced a “permanent brain injury.” The injury was caused by developing a blood clot. A total of 51 cases are filed in the court and the families of the victims are requesting damages in the amount of up to £100 million.
India started the vaccine rollout on 16th January, 2021. Based on all doses delivered up to that point, the number of possible thromboembolic events was calculated to be 0.61 instances per million doses, or 0.000061.
